Integration of RNA-Seq and Machine Learning Identifies Hub Genes for Empagliflozin Benefitable Heart Failure with Reduced Ejection Fraction

References

• Wang H, Chai K, Du M, et al. Prevalence and Incidence of Heart Failure Among Urban Patients in China: a National Population-Based Analysis. Circ Heart Fail. 2021;14(10):e008406. doi:10.1161/CIRCHEARTFAILURE.121.008406
   PubMed Web of Science ®Google Scholar
• Emmons-Bell S, Johnson C, Roth G. Prevalence, incidence and survival of heart failure: a systematic review. Heart. 2022;108(17):1351–1360. doi:10.1136/heartjnl-2021-320131
   PubMed Web of Science ®Google Scholar
• Napoli C, Bontempo P, Palmieri V, et al. Epigenetic Therapies for Heart Failure: current Insights and Future Potential. Vasc Health Risk Manag. 2021;17:247–254. doi:10.2147/VHRM.S287082
   PubMed Web of Science ®Google Scholar
• Sarno F, Benincasa G, List M, et al. Clinical epigenetics settings for cancer and cardiovascular diseases: real-life applications of network medicine at the bedside. Clin Epigenetics. 2021;13(1):66. doi:10.1186/s13148-021-01047-z
   PubMed Web of Science ®Google Scholar
• Gronda E, Lopaschuk GD, Arduini A, et al. Mechanisms of action of SGLT2 inhibitors and their beneficial effects on the cardiorenal axis. Can J Physiol Pharmacol. 2022;100(2):93–106. doi:10.1139/cjpp-2021-0399
   PubMed Web of Science ®Google Scholar
• McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–3726. doi:10.1093/eurheartj/ehab368
   PubMed Web of Science ®Google Scholar
• Zannad F, Ferreira JP, Pocock SJ, et al. SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials. Lancet. 2020;396(10254):819–829. doi:10.1016/S0140-6736(20)31824-9
   PubMed Web of Science ®Google Scholar
• Liu C, Yin Z, Feng T, et al. An integrated network pharmacology and RNA-Seq approach for exploring the preventive effect of Lonicerae japonicae flos on LPS-induced acute lung injury. J Ethnopharmacol. 2021;264(113364):113364. doi:10.1016/j.jep.2020.113364
   PubMedGoogle Scholar
• Zhang Y, Zhou J, Liu J, et al. RNA-Seq analysis of the protection by Dendrobium nobile alkaloids against carbon tetrachloride hepatotoxicity in mice. Biomed Pharmacother. 2021;137(111307):111307. doi:10.1016/j.biopha.2021.111307
   PubMedGoogle Scholar
• Li L, Gao P, Tang X, et al. CB1R-stabilized NLRP3 inflammasome drives antipsychotics cardiotoxicity. Signal Transduct Target Ther. 2022;7(1):190. doi:10.1038/s41392-022-01018-7
   PubMed Web of Science ®Google Scholar
• Wang J, Li X, Liu Z, et al. Second-generation antipsychotics induce cardiotoxicity by disrupting spliceosome signaling: implications from proteomic and transcriptomic analyses. Pharmacol Res. 2021;170(105714):105714. doi:10.1016/j.phrs.2021.105714
   PubMedGoogle Scholar
• Lee CM, Zhou L, Liu J, et al. Single-cell RNA-seq analysis revealed long-lasting adverse effects of tamoxifen on neurogenesis in prenatal and adult brains. Proc Natl Acad Sci U S A. 2020;117(32):19578–19589. doi:10.1073/pnas.1918883117
   PubMed Web of Science ®Google Scholar
• Benincasa G, Maron BA, Affinito O, et al. Association Between Circulating CD4(+) T Cell Methylation Signatures of Network-Oriented SOCS3 Gene and Hemodynamics in Patients Suffering Pulmonary Arterial Hypertension. J Cardiovasc Transl Res. 2023;16(1):17–30. doi:10.1007/s12265-022-10294-1
   PubMed Web of Science ®Google Scholar
• Triposkiadis F, Xanthopoulos A, Parissis J, et al. Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers. Heart Fail Rev. 2022;27(1):337–344. doi:10.1007/s10741-020-09987-z
   PubMed Web of Science ®Google Scholar
• Paulus WJ, Zile MR. From Systemic Inflammation to Myocardial Fibrosis: the Heart Failure With Preserved Ejection Fraction Paradigm Revisited. Circ Res. 2021;128(10):1451–1467. doi:10.1161/CIRCRESAHA.121.318159
   PubMed Web of Science ®Google Scholar
• Lee N, Heo YJ, Choi SE, et al. Anti-inflammatory Effects of Empagliflozin and Gemigliptin on LPS-Stimulated Macrophage via the IKK/NF-κB, MKK7/JNK, and JAK2/STAT1 Signalling Pathways. J Immunol Res. 2021;2021(9944880):1–11. doi:10.1155/2021/9944880
   Google Scholar
• Meng Z, Liu X, Li T, et al. The SGLT2 inhibitor empagliflozin negatively regulates IL-17/IL-23 axis-mediated inflammatory responses in T2DM with NAFLD via the AMPK/mTOR/autophagy pathway. Int Immunopharmacol. 2021;94(107492):107492. doi:10.1016/j.intimp.2021.107492
   PubMedGoogle Scholar
• Kim SR, Lee SG, Kim SH, et al. SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease. Nat Commun. 2020;11(1):2127. doi:10.1038/s41467-020-15983-6
   PubMed Web of Science ®Google Scholar
• Sun Y, Pinto C, Camus S, et al. Splenic Marginal Zone B Lymphocytes Regulate Cardiac Remodeling After Acute Myocardial Infarction in Mice. J Am Coll Cardiol. 2022;79(7):632–647. doi:10.1016/j.jacc.2021.11.051
   PubMed Web of Science ®Google Scholar
• Bermea K, Bhalodia A, Huff A, et al. The Role of B Cells in Cardiomyopathy and Heart Failure. Curr Cardiol Rep. 2022;24(8):935–946. doi:10.1007/s11886-022-01722-4
   PubMed Web of Science ®Google Scholar
• van den Hoogen P, de Jager SCA, Huibers MMH, et al. Increased circulating IgG levels, myocardial immune cells and IgG deposits support a role for an immune response in pre- and end-stage heart failure. J Cell Mol Med. 2019;23(11):7505–7516. doi:10.1111/jcmm.14619
   PubMed Web of Science ®Google Scholar
• Xu Y, Jiang K, Chen F, et al. Bone marrow-derived naïve B lymphocytes improve heart function after myocardial infarction: a novel cardioprotective mechanism for empagliflozin. Basic Res Cardiol. 2022;117(1):47. doi:10.1007/s00395-022-00956-1
   PubMed Web of Science ®Google Scholar
• Jia L, Zhang Y, Pu F, et al. Pseudogene AK4P1 promotes pancreatic ductal adenocarcinoma progression through relieving miR-375-mediated YAP1 degradation. Aging. 2022;14(4):1983–2003. doi:10.18632/aging.203921
   PubMedGoogle Scholar
• Zhou SW, Su BB, Feng YQ, et al. Expression of GTF2IP23 in breast cancer and it mediated regulation of GTF2I. Zhonghua Zhong Liu Za Zhi. 2019;41(12):918–922. doi:10.3760/cma.j.issn.0253-3766.2019.12.007
   PubMedGoogle Scholar
• Kerwin J, Khan I, Iorns E. Replication Study: a coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Elife. 2020;9. doi:10.7554/eLife.51019
   PubMed Web of Science ®Google Scholar
• Nathany S, Tripathi R, Mehta A. Gene of the month: GTF2I. J Clin Pathol. 2021;74(1):1–4. doi:10.1136/jclinpath-2020-207013
   PubMed Web of Science ®Google Scholar
• Friesen M, Warren CR, Yu H, et al. Mitoregulin Controls β-Oxidation in Human and Mouse Adipocytes. Stem Cell Reports. 2020;14(4):590–602. doi:10.1016/j.stemcr.2020.03.002
   PubMed Web of Science ®Google Scholar
• Averina OA, Permyakov OA, Emelianova MA, et al. Mitochondrial peptide Mtln contributes to oxidative metabolism in mice. Biochimie. 2023;204(136):136–139. doi:10.1016/j.biochi.2022.09.009
   PubMedGoogle Scholar
• Choi M, Kang KW. Mitoregulin controls mitochondrial function and stress-adaptation response during early phase of endoplasmic reticulum stress in breast cancer cells. Biochim Biophys Acta Mol Basis Dis. 2023;1869(1):166570. doi:10.1016/j.bbadis.2022.166570
   PubMed Web of Science ®Google Scholar
• Pereira GAR, Beck-da-Silva L. Iron Deficiency in Heart Failure with Reduced Ejection Fraction: pathophysiology, Diagnosis and Treatment. Arq Bras Cardiol. 2022;118(3):646–654. doi:10.36660/abc.20201257
   PubMed Web of Science ®Google Scholar
• Zhihao L, Jingyu N, Lan L, et al. SERCA2a: a key protein in the Ca(2+) cycle of the heart failure. Heart Fail Rev. 2020;25(3):523–535. doi:10.1007/s10741-019-09873-3
   PubMed Web of Science ®Google Scholar
• Tanai E, Frantz S. Pathophysiology of Heart Failure. Compr Physiol. 2015;6(1):187–214.
   PubMed Web of Science ®Google Scholar
• Pyo RT, Sui J, Dhume A, et al. CXCR4 modulates contractility in adult cardiac myocytes. J Mol Cell Cardiol. 2006;41(5):834–844. doi:10.1016/j.yjmcc.2006.08.008
   PubMed Web of Science ®Google Scholar
• Wei L. Immunological aspect of cardiac remodeling: t lymphocyte subsets in inflammation-mediated cardiac fibrosis. Exp Mol Pathol. 2011;90(1):74–78.
   PubMed Web of Science ®Google Scholar
• Duerr GD, Heine A, Hamiko M, et al. Parameters predicting COVID-19-induced myocardial injury and mortality. Life Sci. 2020;260:118400. doi:10.1016/j.lfs.2020.118400
   PubMed Web of Science ®Google Scholar